Toll Free: 1-888-928-9744

Global Diabetic Nephropathy Market 2014-2018

Published: Mar 14, 2014 | Pages: 64 | Publisher: Technavio | Industry: Pharmaceutical | Report Format: Electronic (PDF)

Diabetic Nephropathy, also referred to as Diabetic Kidney Disease, is a progressive kidney condition that damages the capillaries in the kidneys’ glomeruli. It is a common complication of diabetes and one of the leading causes of chronic kidney disease in the western world. 

This ailment is characterized by progressive decline in the glomerular filtration rate, elevated arterial blood pressure, and persistent albuminuria. Early treatment is crucial to preventing or delaying the onset of diabetic nephropathy. 

The global diabetic nephropathy market is projected to grow at a CAGR of 6% from 2013 to 2018 (forecast period). This is credited to rising incidences of obesity and diabetes across the globe. Reputed industry players are making huge investments in the research & development of drugs for treating diabetic nephropathy. 

Moreover, awareness of patients regarding diabetes and kidney-related problems is also on the rise. These factors will have a favorable impact on market growth. However, stringent regulatory procedures, a time-consuming drug-approval process, and poor therapeutic management of diabetic nephropathy may restrict industry expansion. 

Controlling blood pressure and blood glucose levels limits kidney damage. There are various treatment options for diabetic nephropathy. Disease modifying therapies is the largest and most popular method of treatment. 

Chief sub-segments of disease modifying therapies encompass diuretics, antioxidant inflammation modulator, rennin inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers, monocyte chemo attractants proteins inhibitor, angiotensin-converting enzyme (ACE) inhibitors, and connective tissue growth factor inhibitors. ACE inhibitors are anticipated to grow at the fastest rate over the forecast period. 

North America, Europe, Asia Pacific, and RoW (Rest of the World) are the main geographical markets. Asia Pacific is projected to witness lucrative growth owing to rising incidences of diabetes mellitus amongst its populace. India and China are estimated to account for a majority of the total diabetics in the coming years. India has been declared the ‘Diabetes Capital’ of the world. 

North America is another key regional market. Various governments in this region are spreading awareness of diabetes and related kidney disorders. The diabetic nephropathy industry in Europe will benefit from rising expenditure on treatment of diabetes. Key players in the global diabetic nephropathy market are Novartis International AG, Sanofi S.A., Abbott Laboratories, Merck & Co. Inc., and Pfizer Inc. 
 Table of Contents

1. Executive Summary

2. List of Abbreviations

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings
Product Profiles

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

5. Introduction

6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 DN Market in the US
6.3.1 Market Size and Forecast
6.4 DN Market in Europe
6.4.1 Market Size and Forecast
6.5 Five Forces Analysis

7. Pipeline Snapshot

8. Rate of Incidence and Prevalence

9. Geographical Segmentation
9.1 DN Market in the Americas
9.1.1 Market Size and Forecast
9.2 DN Market in the EMEA Region
9.2.1 Market Size and Forecast
9.3 DN Market in the APAC Region
9.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors

18. Key Vendor Analysis
18.1 Merck & Co. Inc.
18.1.1 Business Overview
18.1.2 Business Segmentation
18.1.3 Key Information
18.1.4 SWOT Analysis
18.2 Mitsubishi Tanabe Pharma Corp.
18.2.1 Business Overview
18.2.2 Key Information
18.2.3 SWOT Analysis
18.3 Novartis AG
18.3.1 Business Overview
18.3.2 Business Segmentation
18.3.3 Key Information
18.3.4 SWOT Analysis
18.4 Sanofi S.A.
18.4.1 Business Overview
18.4.2 Business Segmentation
18.4.3 Key Information
18.4.4 SWOT Analysis

19. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global DN Market 2013-2018 (US$ billion)
Exhibit 3: DN Market in the US 2013-2018 (US$ billion)
Exhibit 4: DN Market in Europe 2013-2018 (US$ billion)
Exhibit 5: Global DN Market by Geographical Segmentation 2013
Exhibit 6: DN Market in the Americas 2013-2018 (US$ billion)
Exhibit 7: DN Market in the EMEA Region 2013-2018 (US$ billion)
Exhibit 8: DN Market in the APAC Region (US$ billion)
Exhibit 9: Global DN Market by Geographical Segmentation
Exhibit 10: Business Segmentation of Merck & Co. Inc.
Exhibit 11: Business Segmentation of Novartis AG
Exhibit 12: Business Segmentation of Sanofi S.A.

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global automotive coatings market size is likely to be valued at USD 27.7 billion by 2022; as per a new research report by Radiant Insights, Inc. Vehicle aesthetics, UV radiation and temperature variation protection and enhance durability are certain

Read More...

Global glycerol market size is likely to exceed USD 3 billion by 2022, as per a new research report by Radiant Insights, Inc. Regulatory push for promoting bio-diesel production is expected to boost glycerol demand over the forecast period, with expe

Read More...

Global automotive ECU market is projected to be valued at USD 45.98 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising use in infotainment systems coupled with high deployment in electric vehicles applications is expected

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global intelligent transportation system (ITS) market is estimated to attain USD 38.68 billion by 2020, as per a new research report by Radiant Insights, Inc. Cost effectiveness along with escalating need for road safety is likely to boost global dem

Read More...
Choose License Type
Single User - US $2500
Multi User - US $3500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: sales@radiantinsights.com

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify